| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.00B | 21.96B | 15.58B | 11.36B | 6.99B | 4.69B |
| Gross Profit | 20.44B | 18.83B | 13.84B | 9.34B | 5.66B | 3.74B |
| EBITDA | 4.50B | 3.65B | 2.95B | 2.01B | 812.00M | 335.00M |
| Net Income | 2.74B | 1.89B | 1.46B | 1.07B | 332.00M | 160.00M |
Balance Sheet | ||||||
| Total Assets | 31.07B | 22.73B | 16.23B | 11.44B | 10.32B | 6.75B |
| Cash, Cash Equivalents and Short-Term Investments | 4.99B | 2.54B | 3.80B | 3.87B | 3.96B | 2.41B |
| Total Debt | 12.81B | 8.44B | 6.18B | 5.42B | 5.28B | 2.89B |
| Total Liabilities | 20.67B | 14.22B | 9.48B | 7.41B | 7.33B | 4.73B |
| Stockholders Equity | 10.17B | 8.51B | 6.75B | 3.24B | 2.37B | 2.02B |
Cash Flow | ||||||
| Free Cash Flow | 2.72B | 1.40B | -256.00M | 870.00M | 542.00M | 162.00M |
| Operating Cash Flow | 3.95B | 2.07B | 1.03B | 1.34B | 614.00M | 187.00M |
| Investing Cash Flow | -4.32B | -5.05B | -2.14B | -507.00M | -469.00M | -1.23B |
| Financing Cash Flow | 1.61B | 1.73B | 1.04B | -921.00M | 1.41B | 1.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥32.53B | 7.68 | ― | 0.11% | 31.33% | 34.22% | |
71 Outperform | ¥30.02B | 12.43 | ― | 0.38% | 18.02% | 46.43% | |
71 Outperform | ¥302.41B | 21.83 | ― | ― | 23.28% | 26.56% | |
63 Neutral | ¥49.37B | 58.36 | ― | ― | 22.37% | 655.34% | |
61 Neutral | ¥20.29B | 26.23 | ― | ― | 28.90% | 29.06% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
55 Neutral | ¥6.88B | 27.11 | ― | ― | 42.83% | 26.89% |